Bartlett & Co Wealth Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-49
Closed -$3.65K 1323
2025
Q4
$3.65K Hold
49
﹤0.01% 1055
2025
Q3
$3.31K Buy
49
+2
+4% +$133 ﹤0.01% 1049
2025
Q2
$3.06K Buy
47
+45
+2,250% +$2.7K ﹤0.01% 1056
2025
Q1
$124 Sell
2
-458
-100% -$30.3K ﹤0.01% 1195
2024
Q4
$33.2K Hold
460
﹤0.01% 723
2024
Q3
$37.5K Hold
460
﹤0.01% 710
2024
Q2
$34.2K Sell
460
-3
-0.6% -$225 ﹤0.01% 730
2024
Q1
$36.1K Buy
463
+3
+0.7% +$223 ﹤0.01% 713
2023
Q4
$32.8K Buy
+460
New +$32K ﹤0.01% 777
2021
Q3
Sell
-73
Closed -$4.87K 996
2021
Q2
$4.87K Hold
73
﹤0.01% 762
2021
Q1
$5.43K Hold
73
﹤0.01% 784
2020
Q4
$5.32K Buy
+73
New +$5.15K ﹤0.01% 787

Other funds holding HOLX

Bartlett & Co Wealth Management's HOLX Position: Q1 2026 in Review

Bartlett & Co Wealth Management sold out of Hologic (HOLX) in Q1 2026, closing a stake of 49 shares — an estimated $3.65K sold.

Bartlett & Co Wealth Management first reported a position in HOLX in Q4 2020 and held it in 12 quarters. The position peaked at $37.5K in Q3 2024. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Bartlett & Co Wealth Management reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 49 Hologic shares in Q1 2026, an estimated $3.65K.
  • Bartlett & Co Wealth Management first reported a position in Hologic in Q4 2020 and held it in 12 quarters.
  • Bartlett & Co Wealth Management's Hologic position peaked at $37.5K in Q3 2024.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.